- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Medical Marketing Economics LLC
BioCentury | Mar 23, 2018
Strategy
Arbiter of value
How ICER is becoming the U.S.’s de facto HTA agency
BioCentury | Feb 24, 2018
Strategy
Patients as pawns
How Vertex and France's health authority actions penalize patients
BioCentury | Apr 15, 2017
Strategy
WAC-a-mol
Why prices for Dupixent, Ocrevus, Austedo may shrink patient but not payer costs
BioCentury | Feb 4, 2017
Strategy
Lawyers, drugs and money
Post-FOURIER: what Amgen needs to do to improve Repatha reimbursement
BioCentury | Dec 8, 2014
Strategy
Pricing gene therapies
Lessons from Glybera on alternative pricing models for gene therapies
BioCentury | Jun 16, 2014
Company News
Chimera Biotec, Kineta, KPI Therapeutics, Life Chemicals, Medical Marketing Economics, MPI Research, Seattle Children's Research Institute autoimmune news
Items per page:
1 - 6 of 6